Novo Nordisk's pricing methods from the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, who has accused the company of selling price gouging, stating the stark distinction involving U.S. costs and those in Europe and copyright.This led Novo Nordisk to perform even further study into better dosages of semaglutide especially for